Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant diseases

New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant... Inflammopharmacology, Vol. 12, No. 3, pp. 211 – 213 (2004)  VSP 2004. Also available online - www.vsppub.com Editorial New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant diseases Many advances in treatment of rheumatic and other chronic diseases have come about through serendipitous discoveries or thinking beyond the boundaries of what is accepted practice. In recent years drug combinations have become widely accepted for use in treating rheumatic conditions, having been established practice now for several decades for treating malignancies. Indeed, much has been learnt from treating cancer that has been applied to rheumatoid arthritis with the use of methotrexate with biological agents, the combinations of cytostats with steroids and so forth. In the opposite way the past decade has seen an explosion of interest in the potential for non-steroidal anti-inflammatory drugs (NSAIDs) in the prevention of colo-rectal and other cancers which had its basis, in part, in observations of the reduced incidence of this condition in rheumatic patients as well in the early studies by the late Prof. Alan Bennett about 3 decades ago of increased production of prostaglandins (PGs), especially PGE , in biopsies of colon and other cancers compared with corresponding normal tissues. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Inflammopharmacology Springer Journals

New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant diseases

Inflammopharmacology , Volume 12 (3) – Aug 1, 2004

Loading next page...
 
/lp/springer-journals/new-combinations-of-anti-inflammatories-for-therapy-of-arthritic-3o9kDUNhLV

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2004 by VSP
Subject
Biomedicine; Pharmacology/Toxicology; Allergology; Rheumatology
ISSN
0925-4692
eISSN
1568-5608
DOI
10.1163/1568560042342284
pmid
15527543
Publisher site
See Article on Publisher Site

Abstract

Inflammopharmacology, Vol. 12, No. 3, pp. 211 – 213 (2004)  VSP 2004. Also available online - www.vsppub.com Editorial New combinations of anti-inflammatories for therapy of arthritic, neurological and malignant diseases Many advances in treatment of rheumatic and other chronic diseases have come about through serendipitous discoveries or thinking beyond the boundaries of what is accepted practice. In recent years drug combinations have become widely accepted for use in treating rheumatic conditions, having been established practice now for several decades for treating malignancies. Indeed, much has been learnt from treating cancer that has been applied to rheumatoid arthritis with the use of methotrexate with biological agents, the combinations of cytostats with steroids and so forth. In the opposite way the past decade has seen an explosion of interest in the potential for non-steroidal anti-inflammatory drugs (NSAIDs) in the prevention of colo-rectal and other cancers which had its basis, in part, in observations of the reduced incidence of this condition in rheumatic patients as well in the early studies by the late Prof. Alan Bennett about 3 decades ago of increased production of prostaglandins (PGs), especially PGE , in biopsies of colon and other cancers compared with corresponding normal tissues.

Journal

InflammopharmacologySpringer Journals

Published: Aug 1, 2004

There are no references for this article.